Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 860 of 6351
-
Smart drugs take on rare salivary gland cancer in new trial
Disease control Recruiting nowThis phase II trial compares the effect of usual treatment of docetaxel chemotherapy plus trastuzumab, to ado-emtansine (T-DM1) in patients with HER2-postive salivary gland cancer that has come back (recurrent), that has spread from where it first started (primary site) to other …
Phase 2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New drug combo shows promise in shrinking Hard-to-Treat breast tumors
Disease control CompletedThe purpose of this clinical trial is to evaluate the efficacy and safety of Fluzoparib combined with docetaxel in sequential paclitaxel combined with cyclophosphamide for HRD-positive, HR+/HER2- early breast cancer. The main question it aims to answer is: Does the proportion of…
Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a Two-Session online therapy ease earthquake trauma?
Symptom relief CompletedThis pilot randomized controlled trial evaluated the preliminary effects of the online EMDR Flash Group Protocol among adults affected by the 2023 Kahramanmaraş earthquakes in Türkiye. Participants were randomly assigned to either the EMDR Flash Group Protocol or a waitlist contr…
Sponsor: Istanbul Galata University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New lupus drug shows promise in major trial
Disease control OngoingThe trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneous (s.c.) injection on top of standard-of-care (SoC) treatment in participants with active systemic lupus erythematosus (SLE).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could an extra shingles shot protect transplant patients?
Vaccine Recruiting nowThe goal of this clinical trial is to learn how well the shingles vaccine (Shingrix) works and how safe it is in adults with kidney failure who are waiting for a kidney transplant, including those who later receive a transplant. The study also aims to find out whether giving an e…
Phase 3 • Sponsor: University of Colorado, Denver • Aim: Vaccine
Last updated Jun 27, 2026 12:05 UTC
-
Could a melanoma drug combo tame rare BRAF cancers?
Disease control Recruiting nowThis clinical trial is looking at a combination of drugs called vemurafenib and cobimetinib. Vemurafenib is approved as standard of care for adult patients with unresectable or metastatic melanoma. Cobimetinib is approved as standard of care in combination with vemurafenib for th…
Phase 2/3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New cocktail of drugs shows promise against tough blood cancer
Disease control CompletedThe purpose of this study is to compare the efficacy and safety of venetoclax combined with CACAG regimen with the traditional "3+7" regimen in the treatment of newly diagnosed acute myeloid leukemia.
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Brain zaps for depression: scientists hunt for clues in electrical signals
Disease control Recruiting nowOf the estimated 30 million Americans who suffer from Major Depressive Disorder, approximately 10% are considered treatment resistant. Deep brain stimulation (DBS) to a region of the brain called the subcallosal cingulate (SCC) is an emerging strategy for treatment resistant depr…
Sponsor: Helen Mayberg, MD • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Bladder cancer patients may skip surgery with new drug combo
Disease control OngoingIntravesical immunotherapy or chemotherapy for non-muscle invasive bladder cancer (NMIBC) is a well-established treatment for preventing or delaying tumor recurrence after tumor resection. For high-risk non-muscle invasive bladder cancer, immunotherapy in the form of intravesical…
Phase 2 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a party drug ease PTSD? new trial tests methylone
Symptom relief CompletedThis study is evaluating the safety, tolerability, and efficacy of methylone in adults with PTSD. The study will be conducted in two parts. * Part A is open-label and will enroll up to 15 participants with PTSD * Part B is randomized (1:1), double-blind, placebo-controlled and w…
Phase 1/2 • Sponsor: Transcend Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New cocktail aims to tackle stomach cancer when first treatment fails
Disease control OngoingThis is a prospective, single arm, multicenter phase II study to assess the effectiveness of Serplulimab, Lenvatinib and Paclitaxel in the treatment of advanced gastric or gastroesophageal junction adenocarcinoma after first-line immunotherapy.
Phase 2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Arterial chemo combo shows promise in stomach cancer trial
Disease control Recruiting nowSOX regimen, consisting of oral S-1 and intravenous oxaliplatin, is the preferred regimen for perioperative chemotherapy for gastric cancer. The goal of this clinical trial is to compare the efficacy and safety between S-1 combined with oxaliplatin by arterial infusion, as neoadj…
Phase 3 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
A gentle brain zap might boost hand skills in kids with cerebral palsy
Symptom relief CancelledThe goal of this study is to test the effects of transcranial direct current stimulation (tDCS) on motor learning and brain plasticity in children with unilateral spastic cerebral palsy (USCP).
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can simple birth kits save lives in flood zones?
Prevention CompletedThe evidence is required to assess the effectiveness of enhanced delivery and newborn kits as compared to standard delivery kits in the flood affected districts that can increase the utilization of services and reduce the delays that are responsible for poor maternal and newborn …
Sponsor: Aga Khan University • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
New hope for never-smokers with advanced lung cancer: experimental drug combo enters phase 2 trial
Disease control Recruiting nowThe goal of this clinical trial is to determine clinical advantages for LP-300 in combination with carboplatin and pemetrexed in the never smoker patient population. The primary objectives of this study are to determine progression-free survival (PFS) and overall survival (OS) in…
Phase 2 • Sponsor: Lantern Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Virtual reality at home: a new hope for stroke recovery?
Disease control CompletedBackground: Stroke is the second leading cause of death worldwide and the primary medical cause of disability. It is estimated that 45% of affected individuals will continue to have moderate or severe functional disabilities throughout their lives. According to the American Strok…
Sponsor: Universitat Politècnica de Catalunya • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo shows promise against hodgkin lymphoma
Disease control CompletedThis study will be held in the clinical oncology department, Helwan University, and Police Hospital, aiming to compare the efficacy and safety of anti-CD30 (BV) + Doxorubicin, Vinblastine, and Dacarbazine (AVD) versus the standard of care Doxorubicin, Bleomycin, Vinblastine, and …
Sponsor: Helwan University • Aim: Disease control
Last updated Jun 26, 2026 17:09 UTC
-
New heart valve replacement could spare patients from major surgery
Disease control Recruiting nowThe purpose of this clinical study is to collect safety and efficacy data of the VDyne System to support Conformitè Europëenne (CE) Mark of the VDyne System.
Sponsor: VDyne, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New trial combines drugs with surgery or radiation to fight advanced prostate cancer
Disease control Recruiting nowItalian multicenter study, will enroll \~566 pts with oligometastatic hormone sensitive prostate cancer who are candidates to receive treatment with apalutamide. After 6 months from the start of treatment, patients will be randomized to receive local treatment based on the inves…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
HIV heart risk targeted: new drug trial aims to quiet arterial inflammation
Disease control Recruiting nowThis is a randomized placebo-controlled study in treated and suppressed HIV-infected individuals aged ≥40 years with either known CVD or 1 CVD risk factor to study the effect of Bempedoic acid (BA) on safety, arterial inflammation as assessed by FDG-PET/CT, lipids, inflammation, …
Phase 2 • Sponsor: Priscilla Hsue, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC